Literature DB >> 30053280

Harmonizing the Calibrator and Microorganism Used in the Folate Microbiological Assay Increases the Comparability of Serum and Whole-Blood Folate Results in a CDC Round-Robin Study.

Ming Zhang1, Maya R Sternberg1, Christine M Pfeiffer1.   

Abstract

Background: Harmonizing critical reagents for the folate microbiological assay (MBA) may improve among-laboratory comparability. Objective: We assessed the comparability of the MBA for serum folate (S-FOL) and whole-blood folate (WB-FOL) in an international comparison study.
Methods: Eight laboratories obtained a kit containing CDC microorganism inoculum (chloramphenicol-resistant Lactobacillus rhamnosus), CDC calibrator (5-methyltetrahydrofolate), and 23 serum and WB hemolysate samples each. Laboratories analyzed the samples in single measurement over 2 d using 4 conditions: in-house microorganism and in-house calibrator (IH-MO & IH-CAL), in-house microorganism and CDC calibrator (IH-MO & CDC-CAL), CDC microorganism and in-house calibrator (CDC-MO & IH-CAL), and CDC microorganism and CDC calibrator (CDC-MO & CDC-CAL). We calculated geometric mean concentrations for each laboratory and condition and compared data to the CDC MBA (target).
Results: The among-laboratory arithmetic mean S-FOL concentrations for the 4 conditions were 30.2, 28.1, 30.0, and 29.9 (group 1, 5-methyltetrahydrofolate IH-CAL) compared with 35.3, 33.3, 33.6, and 30.7 nmol/L (group 2, folic acid IH-CAL), respectively; and 428, 405, 398, and 393 (group 1) compared with 469, 423, 477, and 418 nmol/L (group 2), respectively, for WB-FOL. Differences to the CDC MBA target values were smaller for group 1 (range across conditions; S-FOL: 9.9-21%; WB-FOL: 9.0-18%) compared with group 2 laboratories (S-FOL: 13-30%; WB-FOL: 16-32%) and smaller when CDC reagents were used compared with in-house reagents (S-FOL: 12% compared with 22%; WB-FOL: 13% compared with 25%). A linear mixed model estimated a small microorganism effect (S-FOL: 2.3%; WB-FOL: 2.3%) and a larger mean calibrator effect; folic acid compared with 5-methyltetrahydrofolate calibrator produced 12% higher S-FOL and 15% higher WB-FOL results. When laboratories used CDC reagents, the estimated among-laboratory variability was ∼10% for S-FOL and WB-FOL.
Conclusion: Harmonizing the calibrator and microorganism for the folate MBA has the potential to improve the among-laboratory comparability in future surveys.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30053280     DOI: 10.1093/jn/nxy030

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  6 in total

1.  Folate status in the US population 20 y after the introduction of folic acid fortification.

Authors:  Christine M Pfeiffer; Maya R Sternberg; Mindy Zhang; Zia Fazili; Renee J Storandt; Krista S Crider; Sedigheh Yamini; Jaime J Gahche; WenYen Juan; Chia-Yih Wang; Nancy Potischman; Jennifer Williams; Donna J LaVoie
Journal:  Am J Clin Nutr       Date:  2019-11-01       Impact factor: 7.045

2.  Effect of once weekly folic acid supplementation on erythrocyte folate concentrations in women to determine potential to prevent neural tube defects: a randomised controlled dose-finding trial in Malaysia.

Authors:  Kaitlyn L I Samson; Su Peng Loh; Geok Lin Khor; Zalilah Mohd Shariff; Lisa N Yelland; Shalem Leemaqz; Maria Makrides; Jennifer A Hutcheon; Dian C Sulistyoningrum; Jessica J Yu; Marion L Roche; Luz Maria De-Regil; Tim J Green; Crystal D Karakochuk
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

3.  Red Blood Cell Folate Likely Overestimated in Australian National Survey: Implications for Neural Tube Defect Risk.

Authors:  Shannon E Hunt; Merryn J Netting; Thomas R Sullivan; Karen P Best; Lisa A Houghton; Maria Makrides; Beverly S Muhlhausler; Tim J Green
Journal:  Nutrients       Date:  2020-05-01       Impact factor: 5.717

4.  Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.

Authors:  Kaitlyn L I Samson; Su Peng Loh; Siew Siew Lee; Dian C Sulistyoningrum; Geok Lin Khor; Zalilah Binti Mohd Shariff; Irmi Zarina Ismai; Lisa N Yelland; Shalem Leemaqz; Maria Makrides; Jennifer A Hutcheon; Marion L Roche; Crystal D Karakochuk; Timothy J Green
Journal:  BMJ Glob Health       Date:  2020-12

5.  Folate Forms in RBC and Whole-Blood Lysates Appear Stable When Stored Frozen for 2 Years.

Authors:  Zia Fazili; Neelima Paladugula; Ming Zhang; Christine M Pfeiffer
Journal:  J Nutr       Date:  2021-09-04       Impact factor: 4.687

6.  Study protocol for a randomised controlled trial evaluating the effect of folic acid supplementation beyond the first trimester on maternal plasma unmetabolised folic acid in late gestation.

Authors:  Dian Sulistyoningrum; Tim Green; Debbie Palmer; Thomas Sullivan; Simon Wood; Maria Makrides; Monika Skubisz; Karen P Best
Journal:  BMJ Open       Date:  2020-11-16       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.